Patents Assigned to TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
  • Patent number: 11974947
    Abstract: Medical devices and methods for removing a predetermined portion of soft tissue from a target tissue layer, thereby creating a channel between two side walls of the target tissue layer, are described. The medical device is a cutting tool comprising: an elongated round body extending along a longitudinal axis and having a uniform outer cross-section at a proximal side thereof; a cutting portion at a distal side of the elongated body, comprising at a distal end thereof a cutting edge of a first cross-section being smaller than said outer cross-section, and a distally and continuously decreasing outer cross-section; and a chamber extending along the longitudinal axis inside the cutting tool from said cutting portion, the chamber having dimensions enabling storing of the removed soft tissue portion inside the chamber thereby providing a validation to the channel creation.
    Type: Grant
    Filed: January 18, 2023
    Date of Patent: May 7, 2024
    Assignees: SANOCULIS LTD., TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Gilad Lavi, Yoseph Glovinsky, Vadim Shmukler, Nir Israeli
  • Patent number: 11583442
    Abstract: Medical devices and methods for removing a predetermined portion of soft tissue from a target tissue layer, thereby creating a channel between two side walls of the target tissue layer, are described. The medical device is a cutting tool comprising: an elongated round body extending along a longitudinal axis and having a uniform outer cross-section at a proximal side thereof; a cutting portion at a distal side of the elongated body, comprising at a distal end thereof a cutting edge of a first cross-section being smaller than said outer cross-section, and a distally and continuously decreasing outer cross-section; and a chamber extending along the longitudinal axis inside the cutting tool from said cutting portion, the chamber having dimensions enabling storing of the removed soft tissue portion inside the chamber thereby providing a validation to the channel creation.
    Type: Grant
    Filed: May 31, 2022
    Date of Patent: February 21, 2023
    Assignees: SANOCULIS LTD., TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Gilad Lavi, Yoseph Glovinsky, Vadim Shmukler, Nir Israeli
  • Publication number: 20190180139
    Abstract: Apparatus for analyzing brain MRI, is disclosed. The apparatus comprises an input for receiving a first and a second MRI scans at the beginning and end of a predetermined time interval post contrast administration; a subtraction map former for forming a subtraction map from said first and said second MRI scans by analyzing said scans to distinguish between two primary populations, a slow population, in which contrast clearance from the tissue is slower than contrast accumulation, and a fast population in which clearance is faster than accumulation; and an output to provide an indication of distribution of said two primary populations, wherein said predetermined time period is at least twenty minutes.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 13, 2019
    Applicants: Tel HaShomer Medical Research Infrastructure and S ervices Ltd., Ramot at Tel-Aviv University Ltd.
    Inventors: Leor ZACH, David GUEZ, David LAST, Dianne DANIELS ELMAKIAS, Yael MARDOR
  • Publication number: 20170273906
    Abstract: Provided are liposomes including a lipid membrane enclosing an intraliposomal compartment. The liposomes may encapsulate an iron complex, including an iron moiety and a macromolecule, in the intraliposomal compartment. The liposomes may additionally have a targeting moiety associated with the liposomal membranes. The targeting moiety may be exposed at the liposome's outer surface. The liposomes exhibit an immunomodulatory effect or anti-cancer effect depending on the molar ratio between the lipids forming the lipid membrane and the iron complex. As such, the liposomes can be used to treat types of inflammation, particularly inflammations that are not associated or caused by infection or be used to treat cancer. Further provided are compositions including the disclosed liposomes, methods of using and kits including the liposomes.
    Type: Application
    Filed: June 18, 2015
    Publication date: September 28, 2017
    Applicants: Ramot at Tel-Aviv University Ltd., Tel Hashomer Medical Research Infrastructure and S ervices Ltd.
    Inventors: Jonathan LEOR, Tamar BEN-MORDECHAI, Radka HOLBOVA-GELKOFF, Olga YARENCHYK, Rimona MARGALIT, Inbar ELRON-GROSS, Yifat GLUCKSAM-GALNOY
  • Publication number: 20160279202
    Abstract: The invention provides IL-1 inhibitors, methods and uses thereof for retaining ovarian follicle reserve in a mammalian subject, treating infertility and improving responsiveness and sensitivity to COH. The invention further provides methods for improving oocyte quality and/or survival, specifically for IVF, and kits for combining COH treatment with the sensitizing IL-inhibitors of the invention.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 29, 2016
    Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD., TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S ERVICES LTD.
    Inventors: Yehuda KAMARI, Ruth SHALGI, Shiri URI, Dror HARATS, Aviv SHAISH
  • Publication number: 20160262611
    Abstract: In one embodiment, a portable pupillometer including a testing compartment, at least one ocular disposed on the testing compartment, two or more light sources disposed in the testing compartment and forming a plurality of visual stimuli for a subject looking through the at least one ocular, at least one camera configured to capture images of a pupil of the subject via infrared detection, the images indicating pupillary responses to the two or more light sources, and an interface for connection with a computing device external to the pupillometer, the interface adapted to (i) provide, to the computing device, images from the at least one camera, and (ii) receive, from the computing device, control signals for controlling the plurality of light sources.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 15, 2016
    Applicant: Tel HaShomer Medical Research Infrastructure and S ervices Ltd.
    Inventor: Ygal Rotenstreich
  • Publication number: 20110119774
    Abstract: A composition comprising an extract from an aquatic organism is disclosed. The composition is capable of preventing adhesion of a cell to a surface and is devoid of cytotoxic or cytostatic activity. Medical devices comprising same and methods for preventing or treating a pathological infection using same are also disclosed.
    Type: Application
    Filed: September 21, 2008
    Publication date: May 19, 2011
    Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Amir Zlotkin, Eliahu Zlotkin, Amir Zlotkin
  • Publication number: 20100112568
    Abstract: Provided are methods and kits for determining the probability of a subject diagnosed with probable multiple sclerosis to develop definite diagnosis of multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with probable multiple sclerosis and which further develop definite multiple sclerosis and unaffected subjects. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with probable multiple sclerosis.
    Type: Application
    Filed: December 27, 2007
    Publication date: May 6, 2010
    Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Anat Achiron, Michael Gurevich
  • Publication number: 20100074864
    Abstract: Provided are methods and kits for predicting the prognosis of a subject diagnosed with multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with multiple sclerosis and having good or poor clinical outcome. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with multiple sclerosis.
    Type: Application
    Filed: December 27, 2007
    Publication date: March 25, 2010
    Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Anat Achiron, Michael Gurevich
  • Publication number: 20090222035
    Abstract: Disclosed is a catheter for disconnecting, collecting and removing an intraluminal mass from a luminal aspect of a blood vessel, comprising an elongate catheter body, an elongate tubular element extending proximally from an end of the proximal catheter body portion and an intraluminal mass collector configured for collecting an intraluminal mass from a blood vessel. An exemplary collector has a body portion connected to the proximal portion of the catheter body and a radially expandable portion extending in a proximal direction from the body portion, the expandable portion having a reduced diameter configuration with a reduced cross sectional size and at least one expanded diameter configuration. The exemplary catheter additionally includes a disconnector configured for disconnecting an intraluminal mass from a luminal aspect of a blood vessel located proximally from the collector.
    Type: Application
    Filed: March 26, 2007
    Publication date: September 3, 2009
    Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventor: Jacob Schneiderman